Dr. P.S. Gautam
Dr. P. S. Gautam, DM (Cardiology), FACC, is a distinguished Senior Interventional Cardiologist with over 20 years of experience in advancing cardiovascular care. A graduate of the prestigious Nizam’s Institute of Medical Sciences (NIMS), Hyderabad, where he earned his DM in Cardiology and dedicated his career to the treatment of complex cardiac conditions and the Advancement Of Interventional Cardiology.
Currently serving as a Consultant Cardiologist at Malla Reddy Narayana Multispeciality Hospital, Dr. Gautam provides specialized patient care, leads innovative clinical practices, and mentors the next generation of medical professionals. He has an impressive record of performing all types of vascular interventions, including complex coronary, peripheral vascular, and aortic procedures. In addition, he is highly skilled in structural heart interventions, addressing both congenital heart diseases and acquired valvular heart conditions. His expertise, coupled with his certification in Heart Failure from the Heart Failure Association of the European Society of Cardiology, makes him a leading authority in managing advanced cardiovascular disorders.
Beyond clinical practice, Dr. Gautam has made significant contributions to medical research on a global scale. He has participated in numerous international clinical trials, including Rocket AF, and is currently collaborating on groundbreaking studies such as Artemis and Athena, which are exploring innovative therapies like IL-1 inhibitors. His active involvement in research highlights his commitment to driving innovation and improving outcomes for patients worldwide.
With his vast experience, global exposure, and dedication to patient care, Dr. P. S. Gautam has established himself as one of the leading cardiologists in India. His vision continues to shape the future of cardiovascular medicine by combining cutting-edge interventions with compassionate, patient-centered care.
He has served as Principal Investigator in multiple major multinational clinical trials, combined with an extensive body of research in publications, highlighting his contribution to global cardiovascular research.